featured image
Regulations

Is the DEA Sabotaging Psychedelic Research? Inside the Push to Schedule DOI and DOC

January 21, 2025
Featuring: Hamilton Morris

In this episode, Joe interviews renowned chemist, filmmaker, and journalist, Hamilton Morris. 

featured image
Subscribe Share

In this episode, Joe interviews renowned chemist, filmmaker, and journalist, Hamilton Morris. 

After originally backing down from its first attempt in 2022, the DEA is once again looking to apply schedule I status to two lesser-known compounds: DOI (2,5-dimethoxy-4-iodoamphetamine) and DOC (2,5-dimethoxy-4-chloroamphetamine). For decades, DOI and DOC have been incredible tools for researchers studying serotonin receptors, showing promise for chronic pain, anxiety, depression, and more.

Originally recorded as a livestream in November, we felt this discussion deserved more attention, as Morris was present during the hearing and saw first-hand the damage that can come from the combination of immense overreach and outdated beliefs.

He talks about:

  • The bureaucratic mess behind so much of what the DEA does
  • The safety profile and research capacity of DOI and DOC and complete lack of data showing recreational use
  • The DEA’s claim that advocates weren’t experts
  • The fight to protect the Sonoran Desert toad

and more!

While we wait for the conclusion of the hearing, head to Hamilton’s Patreon to hear his daily breakdowns.

Links

Watch this episode on YouTube

Hamiltonmorris.com

Hamilton Morris patreon

PT Live: Joe Moore & Students for Sensible Drug Policy (SSDP) Discuss the DEA’s Hearing on DOI & DOC

SSDP.org: Stop the DEA from Scheduling DOI & DOC!

PT268 – PCP, 5-MeO-DMT, and The Synthesis of New Psychedelics, featuring: Hamilton Morris

ham

In this Episode

Hamilton Morris

Hamilton Morris is a chemist, filmmaker, and science journalist. He uses an interdisciplinary approach combining anthropology and chemistry in the study of psychoactive plants, fungi, chemicals, and the cultures that surround them in more than 30 countries. Hamilton is the director of the award-winning documentary series, Hamilton’s Pharmacopeia, in which he explores the chemistry and traditions surrounding psychoactive drugs. Hamilton attended the University of Chicago and The New School in New York City, where he studied anthropology and science. He frequently consults with media on the subject of psychoactive drugs and conducts pharmacological research at the University of the Sciences in Philadelphia.

Socials: Instagram / Facebook / X / YouTube

Load more podcasts